If you are:
FDB Only When Necessary: MAY CAUSE EP SIGNS & METHEMOGLOBINEMIA IN NEONATES EXPOSED DURING BIRTH
Precaution: MONITOR NURSING INFANT FOR EPS AND METHEMOGLOBINEMIA
An adult over 60:
management or monitoring precaution: General-Avoid high doses and long duration of use. AVOID treatment for longer than 12 weeks. Neuro/Psych-Neurological and psychiatric adverse effects observed with greater risk of tardive dyskinesia. Risk of developing parkinsonian-like reactions increases with ascending doses; discontinue use if they occur. Sedation is more common in elderly and contributes to increased confusion and falls. Renal-Renal assessment and dose reduction even with starting dose if CrCL < 61mL/min.
Giving metoclopramide HCl to a child under 12:
Contraindication: Extrapyramidal effects more likely to occur in children age < 1 year. Rare risk of tardive dyskinesia with prolonged administration. Risk of methemoglobinemia in neonates.
Severe Precaution: Increased risk of extrapyramidal effects, dystonia. Rare risk of tardive dyskinesia with prolonged administration. Not recommended per manufacturer.